BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23/07/2024

FDA Releases Draft Guidance on Postapproval Manufacturing Changes for Biosimilar and Interchangeable Biosimilar Products

The FDA has published a draft guidance document addressing postapproval manufacturing changes for biosimilar and interchangeable biosimilar products, providing answers to frequently asked questions from applicants and other stakeholders.

Source: Federal Register — Food and Drug AdministrationOpen original release →